FRT [UNDERPERFORM -15.0%] - Positive pharmacy progress but share price overshooting

- We downgrade our rating from MARKET PERFORM to UNDERPERFORM despite raising our target price by 46% as FRT’s share price has rallied 65% in the last three months.